EUVIMEDEUVIMED entdecken
Crossref

Evaluating the Immunological Properties of Recombinant Hepatitis B Surface Antigen Using a Multitiered In Vivo and In Vitro Approach

Xuan Zhao, Tianshu Shao iD, Wendong Li, Hong Ji, Yali Zeng, Chunran Cao

Viral Immunology · 2025

DOI: 10.1177/08828245251389235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viral Immunology, 2025. Verfasst von Xuan Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Institute for Drug Control, Beijing, China. Hauptthemen laut MEDLINE: Hepatitis B Surface Antigens, Hepatitis B Antibodies, Immunogenicity, Vaccine. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The immunological properties of recombinant hepatitis B surface antigen (rHBsAg), prepared using yeast ( Saccharomyces cerevisiae [SC]) and Chinese hamster ovary (CHO) cells, were evaluated through in vitro and in vivo assays to support the efficacy of recombinant hepatitis B vaccines. In vitro , antigenicity was assessed by measuring the affinity of rHBsAg to anti-HB antibodies using surface plasmon resonance. In vivo, mice were intraperitoneally injected with 3 µg of simulated vaccines containing anti-HB antibodies absorbed onto aluminum hydroxide adjuvant. Humoral responses were evaluated by measuring serum anti-HB antibody titers and seroconversion rates on days 7, 14, 21, and 28. Cellular immune responses were assessed based on cytokine (Interferon-γ-IFN-γ) and (Tumor Necrosis Factor-α- TNF-α) production from splenic lymphocytes on day 28 postimmunization. A recombinant Huh-7-HBsAg cell line, developed to analyze cellular immune responses, was established through cytotoxicity and apoptosis assays. In vitro , the equilibrium dissociation constant (K D ) of rHBsAg from CHO cells was significantly lower than that from yeast cells, indicating stronger antibody affinity. In vivo , rHBsAg-CHO induced faster and higher antibody titers compared with rHBsAg-SC. Cellular responses showed higher levels of TNF-α and IFN-γ for rHBsAg-CHO. In addition, the rHBsAg-CHO group exhibited higher late apoptosis rates in target cells. The rates induced in the rHBsAg-CHO and rHBsAg-SC groups were 25.0% and 19.2%, respectively. In conclusion, this study demonstrates that the immunological properties of rHBsAg vary based on the expression systems and provides nonclinical data supporting the evaluation of vaccine efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B Surface AntigensHepatitis B AntibodiesImmunogenicity, VaccineRecombinant ProteinsCHO CellsSaccharomyces cerevisiaeVaccines, SyntheticInjections, IntraperitonealAluminum HydroxideAdjuvants, ImmunologicHumansAnimalsMiceCell Line, TumorInterferon-gammaTumor Necrosis Factor-alphaCricetulusSeroconversionMice, Inbred BALB CSpecific Pathogen-Free OrganismsFemaleHepatitis BHepatitis B virus

Stichwörter der Autor:innen

cytokinesimmunogenicity evaluationmodel cellsquality controlrecombinant hepatitis B surface antigen (rHBsAg)surface plasmon resonancevaccine

Substanzen

Hepatitis B Surface AntigensRecombinant ProteinsVaccines, SyntheticHepatitis B AntibodiesAluminum HydroxideAdjuvants, ImmunologicInterferon-gammaTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Beijing Institute for Drug Control, Beijing, China.

ORCID-Profile: Tianshu Shao

Zitieren

APA

Zhao, X., Shao, T., Li, W., Ji, H., Zeng, Y., & Cao, C. (2025). Evaluating the Immunological Properties of Recombinant Hepatitis B Surface Antigen Using a Multitiered In Vivo and In Vitro Approach. Viral Immunology. https://doi.org/10.1177/08828245251389235

Vancouver

Zhao X, Shao T, Li W, Ji H, Zeng Y, Cao C. Evaluating the Immunological Properties of Recombinant Hepatitis B Surface Antigen Using a Multitiered In Vivo and In Vitro Approach. Viral Immunology. 2025. doi:10.1177/08828245251389235

BibTeX
@article{Zhao2025,
  author = {Zhao, Xuan and Shao, Tianshu and Li, Wendong and Ji, Hong and Zeng, Yali and Cao, Chunran},
  title = {Evaluating the Immunological Properties of Recombinant Hepatitis B Surface Antigen Using a Multitiered In Vivo and In Vitro Approach},
  journal = {Viral Immunology},
  year = {2025},
  doi = {10.1177/08828245251389235}
}
Kostenlos starten →